Difference between revisions of "Non-invasive breast carcinoma"
(→Ductal neoplasia: change hierarchy) |
(re-arr. rm text duplicated in tabular form) |
||
Line 8: | Line 8: | ||
=Ductal neoplasia= | =Ductal neoplasia= | ||
==Overview== | |||
This category includes: | This category includes: | ||
#Atypical ductal hyperplasia (ADH). | #Atypical ductal hyperplasia (ADH). | ||
Line 15: | Line 16: | ||
#The degree of '''nuclear atypia'''; high grade is DCIS. | #The degree of '''nuclear atypia'''; high grade is DCIS. | ||
#The '''extent'''; small lesions are ADH, large lesions (low-grade) DCIS. | #The '''extent'''; small lesions are ADH, large lesions (low-grade) DCIS. | ||
==Is it ductal neoplasia?== | |||
===FEHUT versus ADH versus DCIS=== | |||
*Breast duct lumen with too many cells; this is common problem is breast pathology.<ref name=Ref_BP167-8>{{Ref BP|167-8}}</ref> | |||
**The general DDx for this scenario is: ''EHUT'' versus ''ADH'' versus ''DCIS''. | |||
Notes: | |||
*EHUT = epithelial hyperplasia of the usual type, [[AKA]] ''florid epithelial hyperplasia of the usual type'' (FEHUT). | |||
*ADH = atypical ductal hyperplasia. | |||
*DCIS = ductal carcinoma in situ. | |||
====Tabular comparison==== | |||
Comparison of EHUT, ADH and DCIS (memory device: ''CLEAN'' = cell uniformity, luminal spaces, extent/size, arch., nuclei): | |||
{| class="wikitable" | |||
| || '''EHUT''' || '''ADH''' || '''DCIS''' | |||
|- | |||
| '''Cellular composition''' || varied || focal uniformity || uniform | |||
|- | |||
| '''Lumina''' || slits/irregular spaces; <br>cells haphazardly <br>arranged around lumen || irregular spaces, no slits || circular "punched-out"; <br>cells size-by-size + <br>equally spaced @ interface | |||
|- | |||
| '''Extent''' || usually lobulocentric || limited extent || extensive | |||
|- | |||
| '''Architecture''' || irregular/swirling || DCIS-like || DCIS architecture (solid, <br>cribriform, papillary, micropapillary) | |||
|- | |||
| '''Nuclei (intranuclear<br>spacing)''' || variable || hyperchromatic<br>& uniform || evenly spaced | |||
|- | |||
|} | |||
Treatment - implications: | |||
*EHUT - nothing; EHUT is benign. | |||
*ADH - simple excision, i.e. lumpectomy. | |||
*DCIS - excision (lumpectomy) + radiation. | |||
*Invasive ductal carcinoma - excision with sentinel lymph node disection<ref>Sentinel Lymph Node Biopsy: What Breast Cancer Patients Need to Know. cancernews.com. URL: [http://www.cancernews.com/data/Article/202.asp http://www.cancernews.com/data/Article/202.asp]. Accessed on: 9 October 2009.</ref> and radiation. | |||
==Ductal carcinoma in situ== | ==Ductal carcinoma in situ== | ||
Line 75: | Line 109: | ||
*If no RBCs are present to compare with compare the nuclei to one another. | *If no RBCs are present to compare with compare the nuclei to one another. | ||
*If you see nuclei >3x larger than their neigbour you're ready to call DCIS Grade 3. | *If you see nuclei >3x larger than their neigbour you're ready to call DCIS Grade 3. | ||
=Lobular neoplasia= | =Lobular neoplasia= |
Revision as of 00:16, 29 November 2010
Non-invasive breast cancer is a common entity... since the introduction of radiologic breast screening.
It can neatly be divided into the discussion of two entities:
- Ductal carcinoma in situ, and,
- Lobular carcinoma in situ.
Invasive breast cancer is dealt with in the article invasive breast cancer.
Ductal neoplasia
Overview
This category includes:
- Atypical ductal hyperplasia (ADH).
- Ductal carcinoma in situ (DCIS).
The difference between ADH and DCIS is:
- The degree of nuclear atypia; high grade is DCIS.
- The extent; small lesions are ADH, large lesions (low-grade) DCIS.
Is it ductal neoplasia?
FEHUT versus ADH versus DCIS
- Breast duct lumen with too many cells; this is common problem is breast pathology.[1]
- The general DDx for this scenario is: EHUT versus ADH versus DCIS.
Notes:
- EHUT = epithelial hyperplasia of the usual type, AKA florid epithelial hyperplasia of the usual type (FEHUT).
- ADH = atypical ductal hyperplasia.
- DCIS = ductal carcinoma in situ.
Tabular comparison
Comparison of EHUT, ADH and DCIS (memory device: CLEAN = cell uniformity, luminal spaces, extent/size, arch., nuclei):
EHUT | ADH | DCIS | |
Cellular composition | varied | focal uniformity | uniform |
Lumina | slits/irregular spaces; cells haphazardly arranged around lumen |
irregular spaces, no slits | circular "punched-out"; cells size-by-size + equally spaced @ interface |
Extent | usually lobulocentric | limited extent | extensive |
Architecture | irregular/swirling | DCIS-like | DCIS architecture (solid, cribriform, papillary, micropapillary) |
Nuclei (intranuclear spacing) |
variable | hyperchromatic & uniform |
evenly spaced |
Treatment - implications:
- EHUT - nothing; EHUT is benign.
- ADH - simple excision, i.e. lumpectomy.
- DCIS - excision (lumpectomy) + radiation.
- Invasive ductal carcinoma - excision with sentinel lymph node disection[2] and radiation.
Ductal carcinoma in situ
General
- Abbreviated DCIS.
- Diagnosis based on nuclear abnormalities and architecture.
- It is typically picked-up during radiologic screening.
Subtypes
Subtypes are based on architecture:
- Solid.
- No spaces between cells.
- Cribriform.
- Honeycomb-like appearance: circular holes.
- "Cookie cutter" appearance/"punched-out" appearance/"Roman bridges" -- cells surround the circular holes.
- Papillary.
- Papillae with fibrovascular cores.
- Micropapillary.
- Small papillae without fibrovascular cores.
- Have "drum stick" shape.
NOTE: comedonecrosis - used to be considered a separate subtype -- essentially solid type DCIS with necrosis.
Microscopic
Features:
- Nuclear pleomorphism -- most important feature.
- Nuclear size - compared to RBCs to grade DCIS.
- Compare sizes of nuclei if you cannot find RBCs.
- See Grading DCIS for details.
- Compare sizes of nuclei if you cannot find RBCs.
- +/-Mitoses.
- Cells cohesive.
- No spaces in between.
- Nuclei spaced equally.
Size criteria for low-grade DCIS
DCIS must meet the following size criteria:[3]
- Two membrane-bound spaces - OR - 2 mm.
- If it isn't (low-grade) DCIS... it's atypical ductal hyperplasia (ADH).
The treatment is similar; ADH and DCIS are both excised.
The differences are:
- DCIS is cancer, i.e. this has life insurance implications.
- Radiation treatment - DCIS is irradiated; ADH does not get radiation.
Grading DCIS
Graded 1-3 (low-high)[4] - compare lesional nuclei to one another.
- Grade 1
- Nuclei 2-3x size of RBC.
- NO necrosis.
- Grade 2
- Nuclei 2-3x size of RBC.
- +/-Necrosis.
- Grade 3
- Nuclei >3x size of RBC.
- Necrosis usually present.
Notes:
- It is often hard to find RBCs when you want 'em. DCIS is pleomorphic.
- If no RBCs are present to compare with compare the nuclei to one another.
- If you see nuclei >3x larger than their neigbour you're ready to call DCIS Grade 3.
Lobular neoplasia
Overview
Includes:
- Atypical lobular hyperplasia (ALH).
- Lobular carcinoma in situ (LCIS).
- These entities (ALH, LCIS) are near identical from a histomorphologic perspective.
- The difference is extent of involvement:
- ALH <50% of terminal duct lobular unit (TDLU) is involved.
- LCIS >=50% of TDLU is involved.
Atypical lobular hyperplasia
- Abbreviated ALH.
Microscopic
See LCIS.
Lobular carcinoma in situ
- Abbreviated LCIS.
General
- Management is currently some matter of debate.
- Not detected radiologically - it is an incidental pathologic finding.
Microscopic
- Cells distend the duct.
- Dyscohesive - distinct cell border visible.
- Clear cytoplasm (focally); may have signet ring cell-like appearance.
- Eccentrically placed round nucleus,
- Usually minimal atypia, relatively small ~1-2x size lymphocyte.
- +/-Nucleolus.
Subclassification[6]
- Non-PLCIS.
- Type A.
- Nucleus 1-1.5x lymphocyte.
- No nucleolus.
- Type B.
- Nucleus ~2x lymphocyte.
- Nucleolus present.
- Type A.
- PLCIS (pleomorphic lobular carcinoma in situ).
Main DDx:
- Low-grade DCIS.
See also
References
- ↑ O'Malley, Frances P.; Pinder, Sarah E. (2006). Breast Pathology: A Volume in Foundations in Diagnostic Pathology series (1st ed.). Churchill Livingstone. pp. 167-8. ISBN 978-0443066801.
- ↑ Sentinel Lymph Node Biopsy: What Breast Cancer Patients Need to Know. cancernews.com. URL: http://www.cancernews.com/data/Article/202.asp. Accessed on: 9 October 2009.
- ↑ O'Malley, Frances P.; Pinder, Sarah E. (2006). Breast Pathology: A Volume in Foundations in Diagnostic Pathology series (1st ed.). Churchill Livingstone. pp. 168. ISBN 978-0443066801.
- ↑ http://surgpathcriteria.stanford.edu/breast/dcis/
- ↑ Weedman Molavi, Diana (2008). The Practice of Surgical Pathology: A Beginner's Guide to the Diagnostic Process (1st ed.). Springer. pp. 188. ISBN 978-0387744858.
- ↑ 6.0 6.1 O'Malley, Frances P.; Pinder, Sarah E. (2006). Breast Pathology: A Volume in Foundations in Diagnostic Pathology series (1st ed.). Churchill Livingstone. pp. 170. ISBN 978-0443066801.